74. Patients who have congestive heart failure should be cautious when taking pregabalin because the medication has been associated with:
Answer: B
Patients who have congestive heart failure should be cautious when taking pregabalin because the medication has been associated with peripheral edema.
Pregabalin is known to cause peripheral edema, which can exacerbate the symptoms of congestive heart failure. This side effect may lead to fluid retention, making it essential for patients with heart failure to be cautious when using this medication.
A) serotonin syndrome.
Serotonin syndrome is a potentially life-threatening condition that occurs due to excessive serotonergic activity in the central nervous system. Pregabalin is not primarily associated with serotonin syndrome, making this option incorrect in the context of concerns for patients with congestive heart failure.
B) peripheral edema.
Peripheral edema is a common side effect of pregabalin, which can lead to increased fluid retention in patients. For those with congestive heart failure, this can worsen their condition and lead to additional complications, confirming this option as the correct answer.
C) hyperglycemia.
Hyperglycemia refers to elevated blood glucose levels and is not a commonly reported side effect of pregabalin. While some medications can affect glucose metabolism, pregabalin's association with hyperglycemia does not relate to the specific concerns of patients with congestive heart failure.
D) weight loss.
Weight loss is not typically associated with pregabalin use; in fact, some patients may experience weight gain instead. Therefore, this option does not pertain to the risks that congestive heart failure patients should consider when taking pregabalin.
Conclusion
Peripheral edema is a significant concern for patients with congestive heart failure taking pregabalin, as it can exacerbate their condition. The other options do not directly relate to the complications that might arise in this patient population, making option B the only correct choice in this context. Understanding these associations is crucial for safe medication management in patients with heart conditions.